|Bid||115.80 x 0|
|Ask||115.90 x 0|
|Day's range||112.95 - 116.35|
|52-week range||61.00 - 124.80|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||33.95|
|Forward dividend & yield||1.80 (1.59%)|
|Ex-dividend date||27 Aug 2020|
|1y target est||117.25|
Radiation therapy equipment maker Elekta on Wednesday reported a big jump in profit in its first quarter even though sales fell because of the COVID-19 pandemic. Acting CEO Gustaf Salford said in an interview that was mainly down to cost control and a strong performance at the company's services business, which increased sales by 7%. Elekta, which is looking for a new chief executive after the CEO's unexpected resignation in June, said group sales were still affected by restrictions leading to delayed installations and so far only China had returned to a normal level of installation.
Elekta AB (publ) (STO:EKTA B) shareholders should be happy to see the share price up 24% in the last month. But that...
Unfortunately for some shareholders, the Elekta (STO:EKTA B) share price has dived 39% in the last thirty days. That...